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Effects of chloride channel blockers on hypoxic injury in rat proximal
tubules. These studies examined the pathways and consequences of
chloride uptake into proximal tubule cells during in vitro hypoxia. The
chloride channel blocker diphenylamine-2-carboxylate (DPC) markedly
reduced the degree of hypoxia-induced membrane damage as measured
by the release of lactate dehydrogenase (LDH). DPC reduced the release
of LDH from hypoxic tubules from 38 2.7% to 16 1.7% after 30
minutes of hypoxia (P < 0.001, N = 16) and also reduced 36C1 uptake by
hypoxic tubules. The reduction in LDH release was not associated with
better preservation of cell ATP content or with protection against
hypoxia-induced DNA damage. Other C1 channel blockers, such as niflumic
acid, 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB) and 2-[(2-cyclopen-
tyl-6,7-dichloro-2,3-dihyrdo-2-methyl-1-oxo- IH-inden-5-yl)oxy] acetic acid(IAA-94) provided even greater protection than DPC and were as
effective as 2 mrt glycine. The CI channel blockers appear to act late in
the course of hypoxic injury since DNA damage, an early manifestation of
injury, is not prevented by the blockers and since addition of the C1
channel blocker after the hypoxic injury has begun reduces further
membrane damage. These results support the conclusion that transport
through C1 channels contributes to hypoxic cell injury in proximal tubular
cells.
The mechanisms leading to proximal tubular cell injury during
renal ischemia remain incompletely defined. It has been suspected
for some time, however, that the uptake of solute, mainly sodium
and chloride, with subsequent cell swelling contributes to ischemic
cell injury. In support of this view, first articulated by Leaf [1], are
both in vivo [2] and in vitro studies [3, 4] that demonstrate an
increase in cell chloride content and cell volume following isch-
emia or 'chemical anoxia.' In addition, impermeant solutes such as
mannitol or sucrose are effective in ameliorating ischemic acute
renal failure in vivo [5—7] and reduce cell injury in in vitro models
of proximal tubule ATP depletion [8—10].
In normal renal epithelial cells, the negative membrane poten-
tial keeps the intracellular Cl activity in the range of 20 to 25 mst
[Ii]. In energy-deprived cells, depolarization of the membrane
potential due to cellular potassium leak and inhibition of Na,K-
ATPase activity allows CL to enter the cell. While an increase in
cell chloride content during renal ischemia has been demon-
strated, the pathways responsible for the entry of chloride have
not been determined, Several recent studies support the notion
Received for publication December 24, 1994
and in revised form November 19, 1996
Accepted for publication December 5, 1996
© 1997 by the International Society of Nephrology
that C1 channels are present in the basolateral membrane of
proximal tubule cells where they may participate in either net CL
transport or cell volume regulation [11-441. The effect of inhibi-
tion of CL uptake by proximal tubules cells on the subsequent
development of ischemic injury has not been examined directly.
The demonstration of CL channels in proximal tubules, along
with the availability of several classes of agents known to inhibit
CL channels [151 prompted the present studies, which tested the
effect of CL channel blockers on hypoxic proximal tubule cell
injury. The results indicate that several CL channel blockers
provided marked cytoprotection against the hypoxa-induced re-
lease of lactate dehydrogenase (LDH), a marker of lethal cell
injury. These results are consistent with the view that during
hypoxia, and perhaps other forms of injury associated with ATP
depletion, CL uptake occurs via membrane CL channels. More-
over, the transport of CL or other solutes through these channels
contributes to cell injury.
Methods
Preparation of tubule suspensions
Rat proximal tubules were isolated by collagenase digestion and
Percoll gradient ceritrifugation [16, 17]. The isolated proximal
tubules were resuspended at a concentration of —0.5 to I mg
protein/ml and equilibrated for 30 minutes at 37°C in a solution
containing (in mM): 103 NaCl, 5 KCI, 2 NaI-T2P04, 1 MgSO4, I
CaCl2, 5 glucose, 5 malate, 5 glutamate, 4 lactate, 1 alanine, I
valerate, 0.2 dextran-40, 20 HEPES, and 20 NaHCO3 under a
95% 02-5%C02 atmosphere prior to experiments.
Protocol for in vitro hypoxia
Following the 30-minute equilibration period, the tubules were
pelleted by centrifugation and resuspended in the same solution at
a protein concentration of 0.5 to 1.0 mg/mI. Aliquots of tubules (6
to 10 ml) were dispensed into small Erlenmeyer flasks and
incubated in a rotary shaking water bath at 37°C. Throughout the
incubation, the flasks were gassed continuously with either 95%
02:5% CO2 (normoxia) or 95% N2:5% CO2 (hypoxia). At the
indicated times, usually 30 minutes, aliquots of tubules were
removed for measurement of lactate dehydrogenase (LDH) re-
lease or double-stranded DNA (DS-DNA) content. Unless indi-
cated otherwise, test agents were added at the beginning of the
incubation. Diphenylamine-2-carboxylate (DPC) and 5-nitro-2-(3-
phenylpropylamino)-benzoate (NPPB) were added from stock
solutions in DMSO, 2-[(2-cyclopentyl-6,7-dichloro-2,3-dihyrdo-2-
methyl-1-oxo-IH-inden-5-yl)oxy] acetic acid (IAA-94) was added
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from a stock solution in ethanol. Niflumic acid and 4-acetamido-
4'-isothiocyanato-stilbene-2,2'-disulphonic acid (SITS) were
added from aqueous stock solutions. The vehicles alone had no
effect on hypoxia-induced LDH release.
LDH release
A I ml aliquot of tubule suspension was centrifuged through a
2:1 mixture (vol/vol) of dibutyl phthalate and dioctyl phthalate to
separate the tubules from the supernatant fluid. A second aliquot
of tubules was lysed with 0.2% Triton X-100. The LDH activities
in the supernatant and in the tubule lysate were determined
spectrophotometrically from the oxidation of NADH [18].LDH
release into the supernatant was expressed as a percentage of the
total LDH. None of the test agents, or vehicles, interfered with the
assay for LDH.
DNA damage
DNA damage was determined using the alkaline unwinding
assay [19, 20] as reported previously from this laboratory [16]. In
this assay, the rate of DNA unwinding under mild alkaline
conditions is increased by the presence of either single or double-
strand DNA breaks. The amount of residual double stranded
DNA remaining at the end of the alkaline treatment is deter-
mined from the fluorescence of ethidium bromide (tube P). The
fluorescence from non-DNA components in the sample was
determined from a second tube (tube B) that was sonicated prior
to the alkaline incubation in order to introduce a large number of
strand breaks so that there was complete unwinding of the DNA.
The total fluorescence (tube T) was determined from DNA not
exposed to alkaline conditions (pH < 11) so that unwinding was
minimized. The amount of residual double-stranded DNA in tube
P was expressed as a fraction of the total DNA in the sample using
the equation: % residual DS-DNA = (P B)I(T — B) >< 100 [19].
ATP content
The effects of hypoxia on the ATP content of the tubules was
determined from aliquots of tubule suspension removed at the
end of the 30 minutes incubation. Tubules were pelleted by
centrifugation at 1000 g X one minute. The supernatant was
removed quickly and the tubule pellet was extracted into 200 jxl of
10% perchloric acid. The perchloric acid extract was neutralized
with KOH and then diluted 500- to 1000-fold with a 10 mivi Tris
(pH 7.5) buffer. The ATP content of the diluted sample was
determined by mixing 20 xl of sample with 100 .d of a 10 mg/mI
solution of luciferin-luciferase (Sigma Chemical Co.) while mea-
suring the luminescence in a Turner Model TD-20e luminometer.
The ATP content was expressed relative to the protein content of
the tubules determined from the perchloric acid pellet.
36C/ uptake
Six milliliter aliquots of proximal tubule suspensions were
incubated under normoxic or hypoxic conditions for 20 minutes.
At 20 minutes, I Ci/ml of 36Cl - was added to each flask. At the
same time, 1 m DPC was added to one of the hypoxic flasks. At
25 minutes, that is, after five minutes of uptake, 1 ml aliquots of
the suspensions were removed from each flask and immediately
spun through a cushion of phthalate as described above for LDH
release. The supernatants were discarded and the walls of the
tubes were washed three times with water to remove any remain-
ing traces of 36C1 . Finally, the phthalate layer was aspirated and
Fig. 1. Time course of the release of LDH by proximal tubules. Suspensions
of rat proximal tubules were gassed continuously with either 95% °2 or
95% N2 (hypoxia) as described in Methods for 90 minutes. Samples were
removed at the indicated times for measurement of LDH release. P <
0.001 versus normoxia; P < 0.01 versus hypoxia; N = 3. Symbols are: (•)
°2; (U) N2; (A) N2 + DPC.
the tubule pellets were dissolved in 1 N NaOH. The 36CL content
of the tubule lysate, determined by liquid scintillation counting,
was expressed relative to the protein content of the tubule pellet.
Within an experiment, the 36CL content of the hypoxic tubules
(either with or without DPC) was normalized to the 36CL content
of normoxic tubules from the same tubule preparation. All
experiments were performed in triplicate.
Materials
DPC was obtained from Fluka Chemical Co. NPPB was ob-
tained from Biomol Research Laboratory, Inc. IAA-94 was a gift
of Dr. Donald Landry (Columbia University, NY, USA). SITS
was obtained from Molecular Probes, Inc.
Results
The role of CL channels in hypoxic injury to proximal tubules
was examined by testing the effects of the CL channel blocker,
DPC, on the release of LDH during in vitro hypoxia. LDH release,
signifying a loss of membrane integrity to macromolecules, is
generally considered to represent severe, and likely irreversible,
cell damage. The results indicated that 1 mrvi DPC significantly
reduced the release of LDH during hypoxia. Figure 1 shows the
time course of the release of LDH from suspensions of proximal
tubules maintained under either normoxic or hypoxic conditions.
The release of LDH by tubules maintained under oxygen re-
mained low, between 5 and 10%, throughout the 90 minutes
incubation. In contrast, there was a progressive rise in the release
of LDH from hypoxic tubules, beginning at 15 minutes and
exceeding 70% after 90 minutes of hypoxia. Notably, 1 mri DPC
provided significant protection against the hypoxia-induced re-
lease of LDH throughout the entire 90 minutes incubation.
A time point of 30 minutes was selected for further evaluation
of the cytoprotective effects of DPC. Figure 2 presents summary
data for all experiments in which tubules were exposed to 30
minutes of normoxia or hypoxia in the presence or absence of 1
mM DPC. The LDU release from normoxic tubules was 6 0.7%.
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Fig. 3. Effect of hypoxia and DPC on 36C1 uptake by proximal tubules. The
results for hypoxic tubules, with and without DPC, are normalized to the
uptake by normoxic tubules from the same tubule preparation. *P < 0.05
versus hypoxia; p < 0.0001 versus normoxia; N = 3.
Thirty minutes of hypoxia resulted in an increase in LDH release
to 38 2.7%. DPC (1 mM) reduced the LDH release from
hypoxic tubules at 30 minutes to only 14 1.7% (P < 0.001, N =
16). Associated with the decrease in LDH release due to DPC was
a decrease in the uptake of Cl. Figure 3 shows the five minutes
uptake of C1 after 20 minutes of normoxia or hypoxia. Because
of day-to-day variation in the basal rate of Cl uptake between
tubule suspensions, the results for hypoxic tubules are presented
relative to the normoxie controls from the same tubule suspension
(N = 3). The C1 uptake by hypoxic tubules was increased
(158.5 7%) when compared to normoxic tubules. One m DPC
reduced the rate of 36CL uptake in the hypoxic tubules to 114
5% of control (P = 0.035 vs. hypoxia, N = 3). In these experi-
ments, the Cl channel blocker was present only during the five
minute uptake period to minimize indirect effects of the agent due
to improved cell viability.
The ATP content of tubules exposed to hypoxia (1.1 0.2
nmol/mg protein) was significantly lower than that of the nor-
moxie tubules (5.3 0.8 nmol/mg protein, N = 9, P < 0.0001).
The presence of DPC during hypoxia did not affect the ATP
content of tubules (0.9 0.1 nmol/mg protein, N = 4, P> 0.2 vs.
hypoxia), indicating that the reduction in cell injury with DPC was
not due to better preservation of ATP levels. Thus, 1 m'vi DPC
reduced LDH release during hypoxia, and reduced C1 uptake
during hypoxia, but did not affect cell ATP content.
The effect of DPC on the extent of hypoxia-induced DNA
damage in proximal tubule suspensions was also examined (Fig.
4). Tubules incubated in hypoxic solutions for 30 minutes sus-
tained marked DNA damage (50 5% residual DS-DNA vs.
90 2.1% residual DS-DNA in normoxic tubules, P =0.0002). In
contrast to the marked protection provided by DPC against LDH
release, DPC did not significantly reduce the extent of DNA
damage during hypoxia (61 6.8%, N = 5, P> 0.2 vs. hypoxia).
Similarly, 2 miu glycine, another very effective cytoproteetant (Fig.
5) [21], did not protect against DNA damage during hypoxia
(51 4.7% residual DS-DNA, N = 3). Since DNA damage has
been shown to be an early manifestation of hypoxia in proximal
tubules [16, 22], these results are consistent with the view that
DPC, and perhaps glycine, act on later steps in the injury process.
In addition to DPC, several other chloride channel blockers
also provided significant protection against hypoxia-induced LDH
release (Fig. 5). The effects of 2 mrvi glycine are also provided for
comparison. In the absence of any test agents, 30 minutes of
hypoxia increased LDH release from 8 1% to 40 2.4% (P <
0.0001). DPC (1 mM), as noted in Figures 1 and 2, and 2 m
glycine reduced LDH release during hypoxia to 14 1.7 and 9
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Fig. 2. Effect of DPC on the release of LDI-l during hypoxia. The release of
LDH was determined after a 30 minute incubation under either normoxic
or hypoxic conditions. *p < 0.001 versus hypoxia; N = 16.
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Fig. 4. Effect of DPC and 2 msi glycine on DNA damage during hypoxia.
Residual double strand DNA content of tubules at the end of a 30 minute
incubation was determined using the alkaline unwinding assay (Methods).
*P < 0.01 versus normoxia. N = 3 to 6 experiments in each group.
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0
Fig. 5. Cytoprotective effects of C1 channel blockers. LDH release was
measured after 30 minutes of normoxia () or hypoxia (U). The concen-
trations were: glycine (GLY) 2 mtvi, DPC 1 mM, and 100 /LM for the
remaining agents. Data are mean SE. The number of experiments for
each agent is given at the top of the bar. NFA is niflumic acid; other
abbreviations are given in the text. *P < 0.001 versus hypoxia alone.
1.3%, respectively. Clearly, at concentrations of 100 /.LM, a number
of channel blockers such as niflumic acid (NFA) and NPPB were
also very effective, providing virtually complete protection against
LDH release (10 1.1% and 11 2.5%, respectively). IAA-94,
a blocker of outward rectifying CL channels [231 and of certain
CL channels in the renal cortex [24, 251, also was highly effective
in preventing hypoxia-induced LDH release. 1-lowever, not all Cl
channel blockers were cytoprotective. The stilbene compounds
SITS and DNDS, which block outward rectifying Cl channels at
mieromolar concentrations [23, 26, 27], had little effect on LDH
release.
Figure 6 shows the concentration dependence of the cytopro-
tective effects of niflumic acid. The K112 for the cytoprotective
effect (48 fLM) of niflumie acid is similar to the concentrations of
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Fig. 7. Effect of delaying the addition of nifiumic acid on LDH release.
Tubules were incubated under either 02 or N2 (hypoxia) for 30 minutes.
Niflumic acid (NFA) was added at the beginning of the incubation, t = 0,
or after 10 or 20 minutes of hypoxia. The solid bar represents tubules
incubated in the absence of niflumic acid throughout the incubation. Data
are mean SE, N = 3. *p < 0.001 vs. none; *p < 0.005 vs. 02.
niflumic acid, which are required to inhibit certain ligand-gated
Ci channels [28, 291.
The effect of delaying the addition of the chloride channel
blocker on subsequent hypoxic injury was also examined. In these
experiments, 100 j.LM niflumic acid was added to the tubule
suspensions either at the initiation of the hypoxia, or 10 or 20
minutes after the onset of hypoxia. Tubules were sampled after 30
minutes of hypoxia for LDH release. The results (Fig. 7) show that
the cytoprotective effect of the chloride channel blocker is com-
pletely maintained with a 10 minute delay after the onset of
hypoxia. Even after 20 minutes of hypoxia, the subsequent addi-
tion of niflumic acid still reduced LDH release measured at 30
minutes from 49 1.3% to 21 1.0% (P < 0.0001, N 3).
Discussion
Previous studies have demonstrated an increase in the CL
content of proximal tubule cells during ischemia either in vivo [2]
or in Vitro [3] and in chemically-induced ATP depletion in vitro [4].
It has also been proposed that the increase in cell chloride
content, with its attendant increase in cell volume, might contrib-
ute to ischemic cell injury [1]. In this regard, perfusion of kidneys
with solutions containing impermeant solutes such as mannitol or
sucrose, reduces the degree of injury of kidneys subjected to warm
and cold ischemia [30]. Likewise, substitution of chloride by
impermeant anions effectively prolongs the viability of kidneys in
cold storage [311. The pathways for CL influx into proximal
tubule cells during ischemia have not been identified. Likewise,
the effects of inhibiting Cl uptake into hypoxic proximal tubules
on the development of hypoxic injury have not been examined.
Accordingly, given the recent electrophysiologic demonstration of
plasma membrane CL channels in proximal tubule cells, the
effects of Cl channel blockers on the development of hypoxic
injury in proximal tubule suspensions were examined. The results
indicate that certain blockers of CL channels have potent cyto-
protective effects against hypoxia-induced injury to proximal
tubules in vitro. These agents were as effective as 2 mrvt glycine in
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Fig. 6. Concentration dependence of the protection against hypoxia-induced
LDH release by nifiumic acid. The solid line is the best fit of the data to the
Michaelis-Menton relation: % protection = V [niflumic acidl/(kd +[nifiumic acidi). Data are mean SE for 3 to 11 experiments at each
concentration.
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the same system (94.5 4.5% protection, N = 7) [21]. The
cytoprotective effect persisted throughout 90 minutes of hypoxia,
and could be observed even when the blocker was added after
hypoxia was well established.
This laboratory has demonstrated recently that the activation of
potassium channels occurs as an early response to hypoxia in
proximal tubules and contributes to cellular damage [16]. Specif-
ically, the activation of potassium channels appears to be a
proximate event to the initiation of DNA damage during hypoxia.
Blockers of potassium channels provided modest protection
against hypoxia-induced LDH release and almost complete pro-
tection against hypoxia-induced DNA damage [161. The protec-
tive effects of Cl channel blockers seen in the present study
differed from those seen with potassium channel blockers in two
respects. First, the Cl - channel blockers, while providing marked
protection against LDH release, had no effect on hypoxia-induced
DNA damage (Fig. 4). Second, the time course of protection
differed. As shown in Figure 7, the addition of niflumic acid as late
as 20 minutes into the hypoxia still provided significant protection
against LDH release. In the case of potassium channel blockers,
the blockers needed to be present within the first 10 minutes to
prevent DNA damage [16]. Since DNA damage can be demon-
strated within the first five minutes of hypoxia [22], while LDH
release is a marker of advanced cellular injury, the present results
are consistent with the view that CL channel blockers affect an
event late in the cascade of hypoxic injury, but one that precedes
the loss of membrane integrity. Whether or not CL channel
blockers, by blocking a late event in the injury process but not
preserving cellular ATP content or preventing early damage to
DNA (Fig. 4) can actually prevent hypoxic cell death rather than
just delay its onset remains to be determined.
Most CL channel blockers inhibit CL channels with relatively
low affinity and often have effects on other transport systems or
enzymes [15]. For example, niflumic acid, in addition to blocking
several known chloride channels including the CFTR CL chan-
nel, glycine-gated CL channels, and calcium-activated CL chan-
nels [29, 32, 33], is an inhibitor of cyclooxygenase [34]. It is
noteworthy, then, that cytoprotection against hypoxic injury was
provided by several different CL channel blockers belonging to
separate chemical classes. In addition, the concentrations of
niflumic acid required to prevent LDH release are similar to those
required to block CL channels [29, 33], but are 100-fold higher
than those required to inhibit cyclooxygenase [35]. Thus, while
none of these agents is entirely specific for CL channels, the
similar effects of several different CL channel blockers support
the conclusion that the cytoprotection observed in this study was
due to inhibition of Cl channels rather than an interaction with
other pathways. Moreover, at least one of these CL channel
blockers, DPC, reduced the uptake of CL into hypoxic tubules. In
addition, substitution of CL by impermeant anions dramatically
reduced oxidant-induced LDH release from cultured renal epi-
thelial cells (W.B. Reeves, manuscript in preparation). Taken
together, these observations are consistent with the view that CL
entry, via the opening of CL channels, is increased during hypoxia
and contributes to cell injury and the loss of membrane integrity
in that setting. Alternatively, it is possible that the cytoprotective
effects of the CL channel blockers were not due to inhibition of
CL uptake per se, but rather, to other effects such as membrane
hyperpolarization or inhibition of the flux of other solutes through
these channels.
Since these experiments were completed, two other studies
have examined the effects of CL channel blockers on renal
epithelial cell injury [36, 37]. In agreement with the present
results, Waters and Schnellmann [36] found that NPPB, IAA-94,
and niflumic acid reduced both LDH release and CL uptake in
rabbit proximal tubules treated with antimycin A. Venkatachalam
et al [37] also found that certain CL channel blockers reduced
LDH release from MDCK cells treated with the mitochondrial
uncoupler, CCCP. However, in that study, it was necessary to
reduce the extracellular free calcium concentration to 100 flM.tO
observe the effects of CL channel blockers on LDH release.
The identity of the CL channel responsible for the CL entry
during hypoxia is unknown. The pattern of cytoprotection by the
various CL channel blockers, however, resembles the pattern of
inhibition of the CFTR CL channel by these same blockers. A
CFTR-like channel has been identified [38] in the basolateral
membrane of proximal tubule cells. This channel, however, is not
volume-sensitive, and requires ATP for function, so its activity
would likely be low during ischemia. A volume-sensitive anion
channel has been characterized in glial cells, hepatocytes and
erythrocytes [reviewed in 39]. This channel, which also appears to
transport small organic osmolytes, is inhibited by NPPB and
niflumic acid but is only moderately sensitive to stilbene com-
pounds. It is possible that this channel, or a similar channel, is
present in the renal proximal tubule and accounts for the cyto-
protective effects of the CL channel blockers reported here.
Miller and Schnellmann have suggested that a ligand-gated CL
channel similar to the glycine-gated CL channel in the CNS may
mediate CL influx during ATP depletion and also account for the
cytoprotective effects of glycine [4]. They demonstrated that
strychnine, an antagonist to the CNS glycine-gated CL channel,
was cytoprotective against metabolic inhibitors in rabbit proximal
tubule suspensions, albeit at much higher concentrations than are
required to inhibit the CNS glycine-gated Cl channel. Moreover,
components of the CNS glycine receptor have been identified in
renal cortex by Western blot analysis [40] and RT-PCR (W.B.
Reeves, unpublished results), Venkatachalam et al [37] also found
that strychnine and ligands of GABA-gated channels were cyto-
protective in MDCK cells exposed to metabolic inhibitors. In the
latter study, CL influx was not measured but was felt to be
unrelated to the cytoprotective effects of the glycine and GABA
receptor ligands [37]. Nonetheless, there are as yet no direct data
to indicate that a glycine or GABA-gated CL channel is involved
in hypoxic renal injury. Clearly, further electrophysiologic studies
will be required to identify the channel responsible for the C1
influx during hypoxia.
In summary, a number of different CL channel blockers were
found to have marked cytoprotective efficacy in an in vitro system
of hypoxia to rat proximal tubules. These observations are con-
sistent with the view that Cl uptake, mediated via CL channels,
is an important step in the development of irreversible hypoxic
cell injury. This finding may have clinical implications as more
potent, less toxic, CL channel blockers are developed.
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Appendix
Abbreviations are: DPC, diphenylamine-2-carboxylate; NPPB, 5-nitro-
2-(3-phenylpropylamino)-ben.zoate; IAA-94, 2-[(2-cyclopentyl-6,7-dichloro-
2,3-dihyrdo-2-methyl-1-oxo-1H-inden-5-yl)oxyj acetic acid; SITS, 4-acet-
amido-4'-isothiocyanato-stilbene-2,2'-disulphonic acid; LDH, lactate de-
hydrogenase.
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